QuiVad
My list

Home / Funds / Janus Henderson Investors UK Limited

Janus Henderson Investors UK Limited

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on Janus Henderson Investors UK Limited by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

60 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publicationFiling
June 2, 2026Saipem SPAItaly0.47%
April 8, 2026Saipem SPAItaly0.58%
July 24, 2025Saipem SPAItaly0.61%
July 23, 2025AbivaxFrance0.27%July 25, 2025
July 21, 2025AbivaxFrance1.16%July 25, 2025
July 18, 2025AbivaxFrance1.07%July 25, 2025
July 17, 2025AbivaxFrance0.89%July 25, 2025
July 16, 2025AbivaxFrance0.76%July 25, 2025
July 5, 2024Smurfit Kappa Group PLCIreland0.01%
March 19, 2024Grifols, S.A.Spain0.53%
March 5, 2024Vivoryon Therapeutics N.V.Netherlands0.00%
March 4, 2024Vivoryon Therapeutics N.V.Netherlands1.24%
February 27, 2024Vivoryon Therapeutics N.V.Netherlands2.97%
February 26, 2024Vivoryon Therapeutics N.V.Netherlands2.80%
February 22, 2024Vivoryon Therapeutics N.V.Netherlands2.72%
February 21, 2024Vivoryon Therapeutics N.V.Netherlands2.61%
February 13, 2024Vivoryon Therapeutics N.V.Netherlands2.51%
February 7, 2024Vivoryon Therapeutics N.V.Netherlands2.39%
January 22, 2024Vivoryon Therapeutics N.V.Netherlands2.23%
January 18, 2024Vivoryon Therapeutics N.V.Netherlands2.10%
January 17, 2024Vivoryon Therapeutics N.V.Netherlands2.02%
January 9, 2024Vivoryon Therapeutics N.V.Netherlands1.90%
December 27, 2023Vivoryon Therapeutics N.V.Netherlands1.80%
December 12, 2023Ubisoft EntertainmentFrance0.10%December 14, 2023AMF
November 14, 2023Vivoryon Therapeutics N.V.Netherlands1.61%
November 10, 2023Vivoryon Therapeutics N.V.Netherlands1.52%
November 7, 2023Vivoryon Therapeutics N.V.Netherlands1.42%
November 2, 2023Vivoryon Therapeutics N.V.Netherlands1.36%
October 31, 2023Vivoryon Therapeutics N.V.Netherlands1.20%
August 25, 2023Vivoryon Therapeutics N.V.Netherlands1.12%
August 22, 2023Vivoryon Therapeutics N.V.Netherlands1.03%
August 8, 2023Vivoryon Therapeutics N.V.Netherlands0.94%
June 28, 2023Vivoryon Therapeutics N.V.Netherlands0.81%
June 26, 2023Vivoryon Therapeutics N.V.Netherlands0.70%
June 22, 2023Vivoryon Therapeutics N.V.Netherlands0.59%
November 1, 2022Basic-Fit N.V.Netherlands0.47%
October 24, 2022Basic-Fit N.V.Netherlands0.50%
October 12, 2022Basic-Fit N.V.Netherlands0.47%
September 7, 2022Basic-Fit N.V.Netherlands0.51%
May 6, 2022Barratt Developments PLCUnited Kingdom0.38%
April 7, 2022Barratt Developments PLCUnited Kingdom0.50%
April 6, 2022Barratt Developments PLCUnited Kingdom0.47%
March 30, 2022Barratt Developments PLCUnited Kingdom0.50%
March 28, 2022Barratt Developments PLCUnited Kingdom0.46%
October 30, 2020Saipem SPAItaly0.48%
October 7, 2020Saipem SPAItaly0.50%
April 5, 2018Banco BPMItaly0.49%
March 21, 2018Banco BPMItaly0.52%
February 9, 2018Banco BPMItaly0.49%
February 8, 2018Banco BPMItaly0.54%

The AMF column opens the filing the fund itself lodged, on the regulator own site.

Download 60 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Janus Henderson Investors UK Limited, data as at June 2, 2026, https://www.quivad.com/detenteur/janus-henderson-investors-uk-limited